Inventor
BAY SYLVIE
FR14 patents
⚠️ This page may combine multiple inventors who share the name “BAY SYLVIE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PASTEUR INSTITUT
6 patentsUS6676946B2Jan 13, 2004
Multiple antigen glycopeptide carbohydrate vaccine comprising the same and use thereof
PASTEUR INSTITUT24 citations86
US10899799B2Jan 26, 2021
Method for preparing multiple antigen glycopeptide carbohydrate conjugates
PASTEUR INSTITUT0 citations60
US12448412B2Oct 21, 2025
Antigenic tripeptides derived from Mycobacterium avium subsp. paratuberculosis S-type strains, derivatives and uses thereof
PASTEUR INSTITUT0 citations59
US11981750B2May 14, 2024
Antigenic tripeptides derived from Mycobacterium avium subsp. paratuberculosis s-type strains, derivatives and uses thereof
PASTEUR INSTITUT0 citations59
US11498942B2Nov 15, 2022
Antigenic tripeptides derived from Mycobacterium avium subsp. paratuberculosis s-type strains, derivatives and uses thereof
PASTEUR INSTITUT0 citations59
US7696326B2Apr 13, 2010
Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof
PASTEUR INSTITUT0 citations37
HOFFMANN LA ROCHE
5 patentsUS10087245B2Oct 2, 2018
Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
HOFFMANN LA ROCHE5 citations81
US11124563B2Sep 21, 2021
Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
HOFFMANN LA ROCHE1 citations70
US10538582B2Jan 21, 2020
Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
HOFFMANN LA ROCHE2 citations70
US9738712B2Aug 22, 2017
Camelid single-domain antibody directed against amyloid beta and methods for producing conjugates thereof
HOFFMANN LA ROCHE5 citations70
US10787505B2Sep 29, 2020
Oligopeptide and methods for producing conjugates thereof
HOFFMANN LA ROCHE0 citations39